ENTITY
New Horizon Health

New Horizon Health (6606 HK)

59
Analysis
Health CareChina
New Horizon Health Limited operates cancer screening technology development business. The Company develops and sells colorectal cancer screening test products, gastric cancer screening test products, and other products. New Horizon Health markets its products throughout China.
more
Refresh
08 Feb 2021 09:26

New Horizon Health IPO Valuation: Healthy Valuation

The company has set the terms for its IPO, where it plans to raise net proceeds of US$176-208m (approx. HK$1.4-1.6bn) through the issuance of 76.6m...

Share
07 Feb 2021 15:13

Suzhou Basecare Medical IPO: Trading Debut

Basecare priced its IPO at HK$27.36 and closed 14% up at HK$31.20 in the grey market. Our DCF sensitivity analysis shows that the IPO price is...

Logo
363 Views
Share
07 Feb 2021 10:01

ECM Weekly (7 February 2021) - Kuaishou, New Horizon, SciClone, Cloopen

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
07 Feb 2021 08:56

New Horizon IPO: Only Undemanding Assumptions Needed

We think the proposed valuation of New Horizon Health's (NHH HK) IPO is reasonable using undemanding assumptions and would participate in the...

Share
05 Feb 2021 13:45

New Horizon Health (诺辉健康) IPO: Room to Fly

We think there is substantial upside from the high end. The line-up of cornerstone investors is strong. We are seeing strong demand from...

Logo
1.9k Views
Share
x